We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Giving Quantitative Meaning to Microscope Images

By Biotechdaily staff writers
Posted on 11 Jul 2002
A team of computer scientists working with cell biologists has created BioSig, a web-based bioinformatic system that links collections of microscope images to a wide variety of quantitative experimental data. More...
The new program can be used by multiple researchers to answer questions and test hypotheses about protein expression, cell morphology, and cellular organization in tissues and cell cultures.

BioSig, which was developed by a multidisciplinary group at the Lawrence Berkeley National Laboratory (Berkeley, CA, USA), gives quantitative meaning to microscope images in a way that promises far-reaching consequences for the field called ‘phenomics'. Phenomics deals with the proteins a genome codes for--how they are regulated and expressed in the cell and how they interact with each other to condition the cell's responses to outside stimuli and a changing microenvironment.

Researchers in the biological sciences have always faced problems due to the complexity of the systems under investigation. Any biological system exhibits significant variations to begin with. Coupled with technical variability in sample preparations, image representation becomes quite heterogeneous: staining is non-uniform, images are noisy, and subcellular compartments can overlap each other.

Each compartment within the cell must be clearly separated from its neighbors in a process called segmentation. BioSig incorporates segmentation program that removes noise and clearly outlines each cell or nucleus in 2-D images as readily as in 3-D ones. The method is completely automatic and does not require human interaction, as other segmentation programs do. The process recognizes curved sections of the envelopes or membranes of nuclei. By calculating individual ‘centroids' from this information, adjacent objects can be distinguished even when they overlap. With further calculation, the location and magnitude of expressed proteins--identified by specific antibodies--can be resolved with great precision.

Two applications that illustrate BioSig's ability to track different variables in complex situations were presented in the July 2002 issue of Computer. One was an in vitro study of how colonies of human breast cells are influenced by the extracellular matrix, while the other was an in vivo study that looked at two important regulatory proteins interacting to control DNA damage response in mouse mammary cells. In the in vitro study, BioSig allowed the researchers to establish the pathways by which radiation and a protein modifier, acting separately and together, affect the formation of crucial structures in human breast cells. In the in vivo study, BioSig was used to quantify a link between an extracellular factor and intracellular response in mouse mammary glands.

BioSig's developers feel that by enabling researchers to save and access large amounts of quantitative information in images, BioSig makes them useful in ways never before practical.





Related Links:
Lawrence Berkeley National Laboratory

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.